A potential prognostic marker for hematologic neoplasms: CD58
CD58 is a glycoprotein receptor widely distributed on histiocytes that binds to CD2, that takes part in constituting the Immunological Synapses (IS) and activating T/NK cells. Aberrant expression of CD58 has been demonstrated to exert a significant impact on the prognosis of hematological tumors, in...
Saved in:
| Main Authors: | Jiajia Cao, Yurong Zhang, Ningning Yue, Shuzhen Xiong, Shuni Zhang, Chongyang Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1586842/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acquired aberrant partial CD3 expression in recurrent Epstein-Barr virus–negative solitary plasmacytoma of tonsil
by: Chenchen Niu, et al.
Published: (2025-07-01) -
Atipical immunophenotype in a littoral cell angioma
by: Čolović Radoje, et al.
Published: (2009-01-01) -
High number of CD14+B7H4+ monocytes is significantly associated with increased concentrations of IL-4, IL-13, IL-10, and TGF-β1 in tumor microcirculation of lung carcinoma
by: Vuković Jelena, et al.
Published: (2021-01-01) -
The efficacy and safety of CD7 chimeric antigen receptor T-cell therapy for hematologic malignancies: a systematic review and meta-analysis
by: Jile Liu, et al.
Published: (2025-01-01) -
Tandem CAR T-cells targeting CD19 and NKG2DL can overcome CD19 antigen escape in B-ALL
by: Jennifer Bolsée, et al.
Published: (2025-05-01)